Ipca Laboratories Limited (IPCALAB.NS) stock analysis

In our weekly check, Ipca Laboratories Limited is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 20 pass, warnings: 2, red flags: 3.

About Ipca Laboratories Limited

Ipca Laboratories Limited is a Healthcare company (Drug Manufacturers - Specialty & Generic) based in India, listed on NSE as IPCALAB.NS.

What our checks show for IPCALAB.NS

Red flags

• Operating profit does not cover the interest bill (0.3x): interest is paid from cash or new debt.
• The dividend takes 436% of profit: little cushion if profit falls.
• The stock has fallen as much as 61% from a peak. Would you have held through that?

Warning signs

• The net margin fell by 3.3 points over 5 years, to 11.8%: the company keeps less of each sale as profit.
• Thinly traded (about 391 thousand shares a day): buying and selling can move the price.

Strengths

• Net debt is only 0.1x a year of EBITDA: the balance sheet has room.
• The gross margin is 64.1% and has risen by 2 points: pricing power is holding.
• Analysts expect earnings per share to grow about 21.7% a year over the next years.
• Analysts expect the net margin to improve by 3.1 points from today's 11.8%.
• Revenue grew 15.6% a year over the last 3 years.
• Earnings per share grew 34.3% a year over the last 3 years.

Next earnings report: 2026-11-05

Similar companies

6446.TW · GLENMARK.NS · 600276.SS · LUPIN.NS · AUROPHARMA.NS · MANKIND.NS

Questions

What grade does Ipca Laboratories Limited (IPCALAB.NS) have?

In our weekly check, Ipca Laboratories Limited is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 20 pass, warnings: 2, red flags: 3. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of IPCALAB.NS stock?

This week's biggest flags for Ipca Laboratories Limited: Weak interest cover, Dividend stretched, Deep past fall. In total 5 of 25 checks show a warning or a red flag.

What does Ipca Laboratories Limited do?

Ipca Laboratories Limited is a Healthcare company (Drug Manufacturers - Specialty & Generic) based in India, listed on NSE as IPCALAB.NS.

When does Ipca Laboratories Limited report earnings next?

The next earnings report is expected on 2026-11-05. We re-run the checks every week, so the grade can change after it.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-10-31

Open the full analysis